• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Med . Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control mu

tetano

Editor, Senior Moderator
Respir Med


. 2021 May 13;184:106464.
doi: 10.1016/j.rmed.2021.106464. Online ahead of print.
Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study


Amit Chopra[SUP] 1 [/SUP], Ali Hani Al-Tarbsheh[SUP] 2 [/SUP], Nidhi J Shah[SUP] 3 [/SUP], Hamid Yaqoob[SUP] 4 [/SUP], Kurt Hu[SUP] 5 [/SUP], Paul J Feustel[SUP] 6 [/SUP], Ronaldo Ortiz-Pacheco[SUP] 7 [/SUP], Kinner M Patel[SUP] 7 [/SUP], Jozef Oweis[SUP] 2 [/SUP], Natalya Kozlova[SUP] 4 [/SUP], Spyridon Zouridis[SUP] 2 [/SUP], Sahar Ahmad[SUP] 7 [/SUP], Oleg Epelbaum[SUP] 4 [/SUP], Woon H Chong[SUP] 8 [/SUP], John T Huggins[SUP] 9 [/SUP], Biplab K Saha[SUP] 10 [/SUP], Edward Conuel[SUP] 2 [/SUP], Hau Chieng[SUP] 2 [/SUP], Jeannette Mullins[SUP] 8 [/SUP], Divyansh Bajaj[SUP] 5 [/SUP], Boris Shkolnik[SUP] 8 [/SUP], Rachel Vancavage[SUP] 11 [/SUP], Nagendra Madisi[SUP] 8 [/SUP], Marc A Judson[SUP] 8 [/SUP]



Affiliations

Abstract

Background: The clinical features and outcomes of mechanically ventilated patients with COVID-19 infection who develop a pneumothorax has not been rigorously described or compared to those who do not develop a pneumothorax.
Purpose: To determine the incidence, clinical characteristics, and outcomes of critically ill patients with COVID-19 infection who developed pneumothorax. In addition, we compared the clinical characteristics and outcomes of mechanically ventilated patients who developed a pneumothorax with those who did not develop a pneumothorax.
Methods: This study was a multicenter retrospective analysis of all adult critically ill patients with COVID-19 infection who were admitted to intensive care units in 4 tertiary care centers in the United States.
Results: A total of 842 critically ill patients with COVID-19 infection were analyzed, out of which 594 (71%) were mechanically ventilated. The overall incidence of pneumothorax was 85/842 (10%), and 80/594 (13%) in those who were mechanically ventilated. As compared to mechanically ventilated patients in the non-pneumothorax group, mechanically ventilated patients in the pneumothorax group had worse respiratory parameters at the time of intubation (mean PaO[SUB]2[/SUB]:FiO[SUB]2[/SUB] ratio 105 vs 150, P<0.001 and static respiratory system compliance: 30ml/cmH[SUB]2[/SUB]O vs 39ml/cmH[SUB]2[/SUB]O, P = 0.01) and significantly higher in-hospital mortality (63% vs 49%, P = 0.04).
Conclusion: The overall incidence of pneumothorax in mechanically ventilated patients with COVID-19 infection was 13%. Mechanically ventilated patients with COVID-19 infection who developed pneumothorax had worse gas exchange and respiratory mechanics at the time of intubation and had a higher mortality compared to those who did not develop pneumothorax.

Keywords: 2; Barotrauma; COVID-19; Coronavirus disease 2019; Incidence; Mortality; Pneumomediastinum; Pneumothorax; SARS-CoV-2.
 
Back
Top Bottom